Meet the four new ACS Board members

New officers selected for 2021

At its August meeting, the American Cancer Society Board of Directors elected officers and directors for the 2021 Board. 

We welcome four new directors who will join the Board on January 1:

Monica M. Bertagnolli, MD, FASCO: Dr. Bertagnolli is the Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology at Harvard Medical School, and a member of the Gastrointestinal Cancer and Sarcoma Disease Centers at Dana-Farber/Brigham & Women’s Cancer Center, where she collaborates with colleagues in medical oncology, radiation oncology, and pathology to treat cancer patients in a tertiary care setting. Dr. Bertagnolli graduated from Princeton University and attended medical school at the University of Utah. She trained in surgery at Brigham and Women’s Hospital and was a research fellow at the Dana-Farber Cancer Institute (DF/BWCC).

Laura Hertz: Ms. Hertz is the co-founder and CEO of Gifts for Good, an innovative, millennial-driven, and socially conscious startup whose mission is to disrupt the world of business gifting. Prior to co-founding Gifts for Good, Ms. Hertz served as the creative director of Cultural Outreach and as an Audit Senior Associate at Deloitte. Ms. Hertz studied Business Administration at UC Berkeley's Haas School of Business and earned her Master’s in Social Entrepreneurship at the University of Southern California Marshall School of Business.

Edison T. Liu, MD: Dr. Liu is the president and CEO of The Jackson Laboratory in Bar Harbor, Maine. Previously, he was the founding executive director of the Genome Institute of Singapore (2001- 2011) and was the president of the Human Genome Organization (HUGO) from 2007-2013. Between 1997 and 2001, he was the scientific director of the National Cancer Institute's Division of Clinical Sciences in Bethesda, Md., where he was in charge of the intramural clinical translational science programs. He obtained his B.S. in chemistry and psychology, as well as his M.D., at Stanford University. He served his internship and residency at Washington University's Barnes Hospital in St. Louis, followed by an oncology fellowship at Stanford.

Robert Winn, MD: Dr. Winn is the director of VCU Massey Cancer Center. In addition to directing the activities of Massey’s 205 research members – researchers and physicians from 38 departments in 3 colleges and 4 schools at VCU – he also manages a research laboratory at VCU. His current basic science research focuses on the translational aspects of the role that proliferation pathways and cellular senescence play in lung cancer. As a pulmonologist, Dr. Winn actively treats veterans each week at the nearby Hunter Holmes McGuire VA Medical Center. Dr. Winn holds a B.A. from the University of Notre Dame and an MD from the University of Michigan Medical School in Ann Arbor. He completed an internship and residency in internal medicine at Rush- Presbyterian-St. Luke’s Medical Center in Chicago and a fellowship in pulmonary and critical care medicine at the University of Colorado Health Sciences Center in Denver.      

The following Board members were elected to serve as officers for 2021:

• John Alfonso, CPA, CGMA - Chair
• Michael T. Marquardt - Vice Chair 
• Carmen E. Guerra, MD, MSCE, FACP - Board Scientific Officer 
• Brian A. Marlow, CFA - Secretary/Treasurer 
• Jeffrey L. Kean - Immediate Past Chair 

Finally, we want to recognize and thank Daniel P. Heist, CPA, William D. Novelli, and Gregory L. Pemberton, Esq., whose service on the Board ends December 31, 2020.

For more details on the 18 directors and five officers, as well as their terms, read the 2021 Board directory.  

A press release will be available later this year to publicly announce our 2021 Board of Directors.

*Shared from MySocietySource.